CAFE D’IDEES | La 2 Cat: Entrevista a Amayra Hernández-Vega
Entrevista a la Dra. Amayra Hernández-Vega , investigadora del instituto de bioingeniería de Catalunya. Se habla sobre las becas Pasqual Maragall Researchers Programme.
Giuseppe Battaglia
Group leader
The IBEC and West China Hospital hold their third joint conference on precision medicine in Barcelona
Barcelona hosted the third IBEC-WCH Precision Medicine Conference this week, an event that further strengthened the strategic alliance between the Institute for Bioengineering of Catalonia (IBEC) and the West China Hospital of Sichuan University (WCHSU). The Chinese delegation visited Spain from 26 to 29 November, taking part in a busy schedule of scientific and institutional activities and exchanges between the two centres.
IBEC research takes third place in the 2025 Vanguardia de la Ciencia Awards
A study led by IBEC has won the 3rd Vanguardia de la Ciencia 2025 Prize. The research, led by Samuel Sánchez Ordoñez and with Meritxell Serra-Casablanca as lead author, proposes an innovative bladder cancer therapy based on nanorobots loaded with radiopharmaceuticals. These nanorobots are capable of moving around the bladder using urine as a source of energy.
LA VANGUARDIA: ¿Dianas artificiales para hacer llegar medicamentos al cerebro?
Daniel Gonzalez-Carter, investigador del Instituto de Bioingeniería de Catalunya (IBEC), lidera el proyecto brain-TAG.
La Razón: Un estudio hispano-chino abre la vía para tratar el alzhéimer con nanotecnología
Diseñan nanopartículas que eliminan los tóxicos que dañan al cerebro y restauran habilidades mentales que parecían perdidas.
IBEC, one of the centres selected by the Pasqual Maragall Foundation for its research grants
Amaya Hernández-Vega, a senior researcher at IBEC, will lead one of the two projects selected in the 2024 call for proposals from the Pasqual Maragall Research Programme, which is dedicated to funding research into Alzheimer’s disease and other neurodegenerative conditions. IBEC also celebrates the participation of Jordi Duran, an associate researcher from the Molecular and Cellular Neurobiotechnology group, who will collaborate on the second selected project.
NOTICIAS CUATRO: Inyecciones para borrar el Alzheimer
Importante avance médico. Un ensayo científico ha logrado revertir el alzhéimer en ratones a través de una terapia basada en nanotecnología y centrada en el sistema vascular Han logrado una recuperación de las capacidades cognitivas equivalentes a un rejuvenecimiento de unos 20 o 30 años en personas. Declaraciones de Lorena Ruiz Perez, Investigadora del IBEC; Giuseppe Battaglia, Lider Bionica Molecular IBEC.
ARA: Una injecció reverteix símptomesde l’Alzheimer en ratolins
L’administració de nanopartícules permet netejar toxines del cervell
EL PERIÓDICO: Científicos de BCN y China revierten el alzhéimer en ratones
Diseñan una novedosa técnica centrada en restaurar la salud vascular con inyecciones de nanopartículas. «En una hora se han empezado a ver resultados».
Scientists reverse Alzheimer’s in mice using nanoparticles
An international team co-led by the Institute for Bioengineering of Catalonia (IBEC) and the West China Hospital Sichuan University (WCHSU) was able to reverse Alzheimer’s in mice after only 3 injections with nanoparticles. The innovative approach to treating the disease focuses on restoring the normal function of the vasculature, rather than acting on neurons or other brain cells, as has usually been done until now. This achievement, published in the Signal Transduction and Targeted Therapy Journal, is a promising step towards an effective treatment for Alzheimer’s disease.